Yang Yong, Han Zihan, Li Xin, Huang An, Shi Jingyi, Gu Jin
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Center of Gastrointestinal Surgery, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Chin J Cancer Res. 2020 Dec 31;32(6):729-741. doi: 10.21147/j.issn.1000-9604.2020.06.06.
In China, colorectal cancer (CRC) ranked fourth and fifth in the highest incidence and mortality rates of all malignancies in 2018, respectively. Although these rates are below the world average, China placed first worldwide in the number of new CRC cases and CRC-related deaths because of its comparatively large population. This disease represents a threat to the health of population and incurs a heavy economic burden on the society and individuals. CRC has various risk factors, including age, sex, lifestyle, genetic factors, obesity, diabetes, gut microbiota status, and precancerous lesions. Furthermore, incidence and mortality rates of CRC are closely related to socioeconomic development levels, varying according to regional and population characteristics. Prevention is the main strategy to reduce incidence and mortality rates of CRC. This can be achieved through strategies stimulating lifestyle changes, healthy diet habits, and early screening for high-risk individuals. To reduce the burden of CRC, public health officials should promote prevention and management of modifiable risk factors through national policies. The rising incidence and mortality rates of CRC in China may be timely curbed by clarifying specific epidemiological characteristics, optimizing early screening strategies, and strictly implementing diagnosis and treatment guidelines. Thus, this study aimed to collect and report the current research status on epidemiology and risk factors of CRC in China.
在中国,2018年结直肠癌(CRC)的发病率和死亡率在所有恶性肿瘤中分别位居第四和第五。尽管这些比率低于世界平均水平,但由于中国人口相对较多,其结直肠癌新发病例数和与结直肠癌相关的死亡人数位居世界第一。这种疾病对人群健康构成威胁,并给社会和个人带来沉重的经济负担。结直肠癌有多种风险因素,包括年龄、性别、生活方式、遗传因素、肥胖、糖尿病、肠道微生物群状态和癌前病变。此外,结直肠癌的发病率和死亡率与社会经济发展水平密切相关,因地区和人群特征而异。预防是降低结直肠癌发病率和死亡率的主要策略。这可以通过促进生活方式改变、养成健康饮食习惯以及对高危个体进行早期筛查的策略来实现。为减轻结直肠癌负担,公共卫生官员应通过国家政策推动对可改变风险因素的预防和管理。通过明确具体的流行病学特征、优化早期筛查策略以及严格执行诊疗指南,中国结直肠癌发病率和死亡率的上升趋势可能会及时得到遏制。因此,本研究旨在收集和报告中国结直肠癌流行病学和风险因素的当前研究现状。